LAG-3 inhibitor
/ Tessa Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 01, 2023
A 78-Year-Old Man With Metastatic Melanoma and a 67-Year-Old Woman With Stage IV Melanoma : Episode 5: The Role of Lymphocyte-Activation Gene 3 (LAG-3) in Metastatic Melanoma
(Targeted Oncology)
- "Hussein Tawbi, MD, PhD, explains that LAG-3 is a marker of T-cell exhaustion, and combining LAG-3 inhibitors with PD-1 inhibitors can reverse this exhaustion, enhancing T-cell effectiveness and showing therapeutic benefits in patients with metastatic melanoma."
Video
1 to 1
Of
1
Go to page
1